SINGAPORE (Dec 18): Former Cordlife Group CEO Jeremy Yee is making a comeback via Clearbridge Health, a healthcare company seeking a listing on the Singapore Exchange’s Catalist board. Clearbridge aims to raise $24.6 million by issuing 88 million shares at 28 cents each. The issue shares represent 18.3% of the enlarged share capital of 481 million shares, which puts the company’s post-invitation market cap at $134.7 million.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply